Skip to main content
. 2021 Jul 12;7(3):00198-2021. doi: 10.1183/23120541.00198-2021

TABLE 2.

Characteristics of patients with and without evidence of infection

Infection No infection p-value
Patients 102 (69.9) 44 (30.1)
Age years 72.3±10.3 69.8±10.7 0.26
Male 65 (63.7) 26 (59.1) 0.6
Frequent exacerbator, hospital 30 (29.4) 12 (27.3) 0.79
Current smoker 32 (31.4) 15 (34.1) 0.75
Smoking history pack-years 46.7±28.5 38.7±21.6 0.1
BMI kg·m−2 25.1±5.8 25.1±5.3 0.97
FEV1 L 1.21±0.49 1.10±0.67 0.42
FEV1 % pred 51.2±18.0 44.0±20.1 0.12
TLCO % pred 37.3±14.8 42.7±19.7 0.1
mMRCD score 4 (3–5) 4 (3–5) 0.81
Days since symptom onset 5 (3–7) 4 (2–14) 0.94
Prior contact with HCP 68 (66.7) 24 (54.5) 0.17
Pre-hospital antibiotics 51 (50) 16 (36.4) 0.13
Pre-hospital OCS 30 (29.4) 6 (13.6) 0.042
CAT total score 30 (25–34) 30 (26–33) 0.98
HADS total score 16 (10–22) 18.5 (9–24) 0.53
BAP-65 class 3 (2–5) 2 (2–3) 0.13
CXR infiltrate 30.4 20.9 0.24
Fever ≥38°C 23.5 0 <0.001
WCC ×109 per L 12.2±4.8 10.0±3.0 0.006
Neutrophils ×109 per L 9.5±4.3 7.0±2.4 <0.001
Eosinophils ×109 per L 0.04 (0.0–0.14) 0.25 (0.08–0.46) <0.001
CRP mg·dL−1 53 (18.7–117) 4 (1.7–7.0) <0.001
pH 7.36±0.08 7.33±0.08 0.04
PvCO2 mmHg 48.1±11.2 54.5±13.8 0.006
Bicarbonate mmol·L−1 27.5±4.2 29.3±5.7 0.13
Base excess mmol·L−1 2.7±3.8 4.1±5.2 0.11
NT-proBNP ng·L−1 395 (164–1221) 263 (152–853) 0.45
hs-TnI ng·L−1 9 (5–32) 8 (5–20) 0.38

Data are presented as n (%), mean±sd or median (interquartile range), unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in 1 s; TLCO: transfer factor of the lung for carbon monoxide; mMRCD: modified Medical Research Council dyspnoea scale; HCP: healthcare provider; OCS: oral corticosteroid; CAT: COPD Assessment Test; HADS: Hospital Anxiety and Depression Scale; BAP-65: blood urea nitrogen ≥25 mg·dL−1, altered mental status, pulse 109 beats per min, age 65 years; CXR: chest radiography; WCC: white cell count; CRP: C-reactive protein; PvCO2: venous carbon dioxide tension; NT-proBNP: N-terminal pro-brain natriuretic peptide; hs-TnI: high-sensitivity troponin I.